...
首页> 外文期刊>European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery >Letter to editor re 'Differential protein expression in serum of abdominal aortic aneurysm patients - A proteomic approach'
【24h】

Letter to editor re 'Differential protein expression in serum of abdominal aortic aneurysm patients - A proteomic approach'

机译:致编辑的信“腹主动脉瘤患者血清中蛋白质差异表达-蛋白质组学方法”

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In their paper "Differential expression in serum of abdominal aortic aneurysm patients - A proteomic approach", Pulinx et al. mined the proteome of patients with AAAs in search of novel biomarkers. They report elevated factor XII and alpha-1 antitrypsin levels in the serum of patients with progressive aneurysms, but found these proteins to have little ability to predict aneurysm progression above the established marker, AAA diameter.I propose that the authors were never likely to discover a putative biomarker using this technique. DIGE has been utilised by scientists across medicine and vascular surgery [including our group] for many years, and although it has provided insight into disease pathogenesis, it has failed to discover a biomarker translatable to clinical practice.Serum is an unstable sensitive protein preparation, which can modify depending on harvest factors including time-of-day, ambient temperature, current health, sex, and age, all factors which have not been controlled for in this study. Given this principle flaw, and the most significant finding being increased expression of ubiquitous Albumin in patients with large AAAs [P = 0.007], the results must be interpreted with caution.
机译:在他们的论文“腹主动脉瘤患者血清中的差异表达-蛋白质组学方法”中,Pulinx等人。挖掘了AAAs患者的蛋白质组以寻找新的生物标志物。他们报告了进行性动脉瘤患者血清中的XII因子和α-1抗胰蛋白酶水平升高,但发现这些蛋白几乎无法预测超过既定标记AAA直径的动脉瘤进展。我建议作者永远不可能发现使用该技术的推定生物标志物。多年来,DIGE已被医学和血管外科领域的科学家[包括我们的小组]使用,尽管它提供了疾病发病机理的见解,但却未能发现可转化为临床实践的生物标志物。血清是一种不稳定的敏感蛋白制剂,可以根据收获因素进行修改,包括一天中的时间,环境温度,当前的健康状况,性别和年龄,这些因素在本研究中均未得到控制。鉴于这一原理缺陷,最重要的发现是在患有大型AAA的患者中普遍存在的白蛋白表达增加[P = 0.007],必须谨慎解释结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号